Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: A promising approach to kill resistant cancer cells?

Cellular and Molecular Life Sciences

Volumn 67, Issue 18, 2010, Pages 3115-3130

  Jacquemin, Guillaume ^a,b   Shirley, Sarah ^a,b   Micheau, Olivier ^a,b,c  

^a boulevard Jeanne d'Arc   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c CENTRE GEORGES FRANÇOIS LECLERC   (France)

Author keywords

Apoptosis; Cancer; DR4; DR5; Flavonoid; Polyphenol; Stilbene; TRAIL

Indexed keywords

APIGENIN; BAICALEIN; BUTEIN; CHALCONE DERIVATIVE; CURCUMIN; DAIDZEIN; EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; FLAVONOLIGNAN; GENISTEIN; HONOKIOL; ISOLIQUIRITIGENIN; KAEMPFEROL; LIGNAN; LUTEOLIN; MYRICETIN; NORDIHYDROGUAIARETIC ACID; POLYPHENOL; QUERCETIN; RESVERATROL; SILIBININ; STILBENE DERIVATIVE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; UNINDEXED DRUG; WOGONIN; ANTINEOPLASTIC AGENT; PHENOL DERIVATIVE; POLYPHENOLS;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER THERAPY; CELL DEATH; CELL TYPE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG ISOLATION; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; HUMAN; NONHUMAN; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; ANIMAL; CHEMISTRY; CLASSIFICATION; DRUG EFFECT; DRUG RESISTANCE; MOUSE; NEOPLASM;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG RESISTANCE, NEOPLASM; FLAVONOIDS; HUMANS; MICE; NEOPLASMS; PHENOLS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 77956642345     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0407-6     Document Type: Review

References (144)

1. A Ashkenazi P Holland SG Eckhardt 2008 Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL) J Clin Oncol 26 3621 3630 1:CAS:528:DC%2BD1cXpvVWmtbw%3D 18640940
2. T Trarbach M Moehler V Heinemann CH Kohne M Przyborek C Schulz V Sneller G Gallant S Kanzler 2010 Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer Br J Cancer 102 506 512 1:CAS:528:DC%2BC3cXhsVSrs7s%3D 20068564
3. T Newsom-Davis S Prieske H Walczak 2009 Is TRAIL the holy grail of cancer therapy? Apoptosis 14 607 623 1:CAS:528:DC%2BD1MXivFSns7Y%3D 19194800
4. A Ashkenazi RC Pai S Fong S Leung DA Lawrence SA Marsters C Blackie L Chang AE McMurtrey A Hebert L DeForge IL Koumenis D Lewis L Harris J Bussiere H Koeppen Z Shahrokh RH Schwall 1999 Safety and antitumor activity of recombinant soluble Apo2 ligand J Clin Investig 104 155 162 1:CAS:528:DyaK1MXkslSmsbw%3D 10411544
5. SK Kelley LA Harris D Xie L Deforge K Totpal J Bussiere JA Fox 2001 Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety J Pharmacol Exp Ther 299 31 38 1:CAS:528:DC%2BD3MXntFWltrw%3D 11561060
6. D Lawrence Z Shahrokh S Marsters K Achilles D Shih B Mounho K Hillan K Totpal L DeForge P Schow J Hooley S Sherwood R Pai S Leung L Khan B Gliniak J Bussiere CA Smith SS Strom S Kelley JA Fox D Thomas A Ashkenazi 2001 Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions Nat Med 7 383 385 1:CAS:528:DC%2BD3MXis1ymtb0%3D 11283636
7. G Zauli P Secchiero 2006 The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology Cytokine Growth Factor Rev 17 245 257 1:CAS:528:DC%2BD28XntFSgsbw%3D 16750931
8. S Boehrer D Nowak D Hoelzer PS Mitrou KU Chow 2006 The molecular biology of TRAIL-mediated signaling and its potential therapeutic exploitation in hematopoietic malignancies Curr Med Chem 13 2091 2100 1:CAS:528: DC%2BD28XnslOksr0%3D 16918339
9. E Cretney A Shanker H Yagita MJ Smyth TJ Sayers 2006 TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer Immunol Cell Biol 84 87 98 1:CAS:528:DC%2BD28Xhs1CqsLk%3D 16405656
10. GE Diehl HH Yue K Hsieh AA Kuang M Ho LA Morici LL Lenz D Cado LW Riley A Winoto 2004 TRAIL-R as a negative regulator of innate immune cell responses Immunity 21 877 889 1:CAS:528:DC%2BD2MXjvFGjuw%3D%3D 15589175
11. EM Janssen NM Droin EE Lemmens MJ Pinkoski SJ Bensinger BD Ehst TS Griffith DR Green SP Schoenberger 2005 CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death Nature 434 88 93 1:CAS:528:DC%2BD2MXhslClsLc%3D 15744305
12. E Cretney K Takeda H Yagita M Glaccum JJ Peschon MJ Smyth 2002 Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice J Immunol 168 1356 1361 1:CAS:528:DC%2BD38XpsFektw%3D%3D 11801676
13. C Schmaltz O Alpdogan BJ Kappel SJ Muriglan JA Rotolo J Ongchin LM Willis AS Greenberg JM Eng JM Crawford GF Murphy H Yagita H Walczak JJ Peschon MR van den Brink 2002 T cells require TRAIL for optimal graft-versus-tumor activity Nat Med 8 1433 1437 1:CAS:528:DC%2BD38XptVSgsbk%3D 12426560
14. A Grosse-Wilde CJ Kemp 2008 Metastasis suppressor function of tumor necrosis factor-related apoptosis-inducing ligand-R in mice: implications for TRAIL-based therapy in humans? Cancer Res 68 6035 6037 1:CAS:528: DC%2BD1cXpt1Sqtrk%3D 18676822
15. P Secchiero G Lamberti F Corallini E Melloni C Guarnotta A Sebastiani G Zauli 2009 Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye J Cell Physiol 218 199 204 1:CAS:528:DC%2BD1cXhsFahsbfE 18780288
16. Bem RA, Bos AP, Wosten-van Asperen RM, Bruijn M, Lutter R, Sprick MR, van Woensel JB (2009) Potential role of soluble TRAIL in epithelial injury in children with severe RSV infection. Am J Respir Cell Mol Biol. doi: 10.1165/rcmb.2009-0100OC
17. LH Han WS Sun CH Ma LN Zhang SX Liu Q Zhang LF Gao YH Chen 2002 Detection of soluble TRAIL in HBV infected patients and its clinical implications World J Gastroenterol 8 1077 1080 1:CAS:528:DC%2BD38XpvVSnsrk%3D 12439929
18. P Schneider N Holler JL Bodmer M Hahne K Frei A Fontana J Tschopp 1998 Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity J Exp Med 187 1205 1213 1:CAS:528:DyaK1cXis1Cru7o%3D 9547332
19. G Pan K O'Rourke AM Chinnaiyan R Gentz R Ebner J Ni VM Dixit 1997 The receptor for the cytotoxic ligand TRAIL Science 276 111 113 1:CAS:528: DyaK2sXitl2jsL4%3D 9082980
20. PM Chaudhary M Eby A Jasmin A Bookwalter J Murray L Hood 1997 Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway Immunity 7 821 830 1:CAS:528:DyaK1cXjsFWrsQ%3D%3D 9430227
21. H Walczak MA Degli-Esposti RS Johnson PJ Smolak JY Waugh N Boiani MS Timour MJ Gerhart KA Schooley CA Smith RG Goodwin CT Rauch 1997 TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL EMBO J 16 5386 5397 1:CAS:528:DyaK2sXmsVGlsLo%3D 9311998
22. P Schneider JL Bodmer M Thome K Hofmann N Holler J Tschopp 1997 Characterization of two receptors for TRAIL FEBS Lett 416 329 334 1:CAS:528:DyaK2sXmvFWjsLc%3D 9373179
23. M MacFarlane M Ahmad SM Srinivasula T Fernandes-Alnemri GM Cohen ES Alnemri 1997 Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL J Biol Chem 272 25417 25420 1:CAS:528:DyaK2sXms1Cqsr4%3D 9325248
24. MA Degli-Esposti PJ Smolak H Walczak J Waugh CP Huang RF DuBose RG Goodwin CA Smith 1997 Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family J Exp Med 186 1165 1170 1:CAS:528:DyaK2sXmsFaqs70%3D 9314565
25. G Pan J Ni YF Wei G Yu R Gentz VM Dixit 1997 An antagonist decoy receptor and a death domain-containing receptor for TRAIL Science 277 815 818 1:CAS:528:DyaK2sXlt1eksro%3D 9242610
26. MA Degli-Esposti WC Dougall PJ Smolak JY Waugh CA Smith RG Goodwin 1997 The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain Immunity 7 813 820 1:CAS:528:DyaK1cXjsFWgtQ%3D%3D 9430226
27. SA Marsters JP Sheridan RM Pitti A Huang M Skubatch D Baldwin J Yuan A Gurney AD Goddard P Godowski A Ashkenazi 1997 A novel receptor for Apo2L/TRAIL contains a truncated death domain Curr Biol 7 1003 1006 1:CAS:528: DyaK2sXotFSls7o%3D 9382840
28. C Scaffidi S Fulda A Srinivasan C Friesen F Li KJ Tomaselli KM Debatin PH Krammer ME Peter 1998 Two CD95 (APO-1/Fas) signaling pathways EMBO J 17 1675 1687 1:CAS:528:DyaK1cXit1Git74%3D 9501089
29. N Ozoren WS El-Deiry 2002 Defining characteristics of types I and II apoptotic cells in response to TRAIL Neoplasia 4 551 557 12407450
30. H LeBlanc D Lawrence E Varfolomeev K Totpal J Morlan P Schow S Fong R Schwall D Sinicropi A Ashkenazi 2002 Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax Nat Med 8 274 281 1:CAS:528:DC%2BD38Xit1Cisb8%3D 11875499
31. C Scaffidi I Schmitz J Zha SJ Korsmeyer PH Krammer ME Peter 1999 Differential modulation of apoptosis sensitivity in CD95 type I and type II cells J Biol Chem 274 22532 22538 1:CAS:528:DyaK1MXlt1CnsLg%3D 10428830
32. BB Aggarwal U Bhardwaj Y Takada 2004 Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors Vitam Horm 67 453 483 1:CAS:528:DC%2BD2cXltlKgtb8%3D 15110190
33. EC LaCasse DJ Mahoney HH Cheung S Plenchette S Baird RG Korneluk 2008 IAP-targeted therapies for cancer Oncogene 27 6252 6275 1:CAS:528: DC%2BD1cXht1GrtLrE 18931692
34. MS Ricci Z Jin M Dews D Yu A Thomas-Tikhonenko DT Dicker WS El-Deiry 2004 Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity Mol Cell Biol 24 8541 8555 1:CAS:528:DC%2BD2cXnvVaktLw%3D 15367674
35. O Micheau J Tschopp 2003 Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes Cell 114 181 190 1:CAS:528: DC%2BD3sXlvFCgu7Y%3D 12887920
36. D Merino N Lalaoui A Morizot P Schneider E Solary O Micheau 2006 Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2 Mol Cell Biol 26 7046 7055 1:CAS:528:DC%2BD28XhtVCltbnK 16980609
37. A Rossin M Derouet F Abdel-Sater AO Hueber 2009 Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling Biochem J 419 185 192 1:CAS:528:DC%2BD1MXjtVShu7k%3D 19090789 (2 p following 192)
38. KW Wagner EA Punnoose T Januario DA Lawrence RM Pitti K Lancaster D Lee M von Goetz SF Yee K Totpal L Huw V Katta G Cavet SG Hymowitz L Amler A Ashkenazi 2007 Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL Nat Med 13 1070 1077 1:CAS:528: DC%2BD2sXhtVSgtrvO 17767167
39. T Yoshida T Shiraishi M Horinaka M Wakada T Sakai 2007 Glycosylation modulates TRAIL-R1/death receptor 4 protein: different regulations of two pro-apoptotic receptors for TRAIL by tunicamycin Oncol Rep 18 1239 1242 1:CAS:528:DC%2BD2sXhtlKhsr%2FK 17914579
40. A Thorburn K Behbakht H Ford 2008 TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them Drug Resist Updat 11 17 24 1:CAS:528:DC%2BD1cXlslWqtbY%3D 18374623
41. L Zhang B Fang 2005 Mechanisms of resistance to TRAIL-induced apoptosis in cancer Cancer Gene Ther 12 228 237 1:CAS:528:DC%2BD2MXhtlahsLc%3D 15550937
42. M Kim SY Park HS Pai TH Kim TR Billiar DW Seol 2004 Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation Cancer Res 64 4078 4081 1:CAS:528: DC%2BD2cXkvFWlsro%3D 15205314
43. D Mahalingam E Szegezdi M Keane S Jong A Samali 2009 TRAIL receptor signalling and modulation: are we on the right TRAIL? Cancer Treat Rev 35 280 288 1:CAS:528:DC%2BD1MXksVantrY%3D 19117685
44. M D'Archivio C Filesi R Di Benedetto R Gargiulo C Giovannini R Masella 2007 Polyphenols, dietary sources and bioavailability Ann Ist Super Sanita 43 348 361 18209268
45. S Ramos 2008 Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways Mol Nutr Food Res 52 507 526 1:CAS:528: DC%2BD1cXms1egt7k%3D 18435439
46. F Depeint JM Gee G Williamson IT Johnson 2002 Evidence for consistent patterns between flavonoid structures and cellular activities Proc Nutr Soc 61 97 103 1:CAS:528:DC%2BD38Xit1WrtLY%3D 12002801
47. M Murzakhmetova S Moldakarimov L Tancheva S Abarova J Serkedjieva 2008 Antioxidant and prooxidant properties of a polyphenol-rich extract from Geranium sanguineum L. in vitro and in vivo Phytother Res 22 746 751 18446846
48. K Sakao M Fujii DX Hou 2009 Clarification of the role of quercetin hydroxyl groups in superoxide generation and cell apoptosis by chemical modification Biosci Biotechnol Biochem 73 2048 2053 1:CAS:528:DC%2BD1MXht1Ghu77O 19734664
49. JB Harborne CA Williams 2000 Advances in flavonoid research since 1992 Phytochemistry 55 481 504 1:CAS:528:DC%2BD3cXosFent74%3D 11130659
50. S Thomasset N Teller H Cai D Marko DP Berry WP Steward AJ Gescher 2009 Do anthocyanins and anthocyanidins, cancer chemopreventive pigments in the diet, merit development as potential drugs? Cancer Chemother Pharmacol 64 201 211 1:CAS:528:DC%2BD1MXlt1Kjtrk%3D 19294386
51. BB Hafeez IA Siddiqui M Asim A Malik F Afaq VM Adhami M Saleem M Din H Mukhtar 2008 A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling Cancer Res 68 8564 8572 18922932
52. M Ding R Feng SY Wang L Bowman Y Lu Y Qian V Castranova BH Jiang X Shi 2006 Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity J Biol Chem 281 17359 17368 1:CAS:528:DC%2BD28XlvVGkt7k%3D 16618699
53. PL Kuo YL Hsu TC Lin LT Lin CC Lin 2004 Induction of apoptosis in human breast adenocarcinoma MCF-7 cells by prodelphinidin B-2 3, 3′-di-O-gallate from Myrica rubra via Fas-mediated pathway J Pharm Pharmacol 56 1399 1406 1:CAS:528:DC%2BD2cXpvFOltb8%3D 15525446
54. J Fleschhut F Kratzer G Rechkemmer SE Kulling 2006 Stability and biotransformation of various dietary anthocyanins in vitro Eur J Nutr 45 7 18 1:CAS:528:DC%2BD28Xis1SgsLo%3D 15834757
55. T Nishikawa T Nakajima M Moriguchi M Jo S Sekoguchi M Ishii H Takashima T Katagishi H Kimura M Minami Y Itoh K Kagawa T Okanoue 2006 A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins J Hepatol 44 1074 1082 1:CAS:528:DC%2BD28XksVaisb4%3D 16481065
56. MD Siegelin A Habel T Gaiser 2008 Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma Neurosci Lett 448 161 165 1:CAS:528:DC%2BD1cXhtlyiurnE 18948169
57. IA Siddiqui A Malik VM Adhami M Asim BB Hafeez S Sarfaraz H Mukhtar 2008 Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis Oncogene 27 2055 2063 1:CAS:528: DC%2BD1cXjslWjtr4%3D 17998943
58. A Basu S Haldar 2009 Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death Int J Oncol 34 281 286 1:CAS:528:DC%2BD1MXht1Cqtrc%3D 19082499
59. Q Shen F Tian P Jiang Y Li L Zhang J Lu J Li 2009 EGCG enhances TRAIL-mediated apoptosis in human melanoma A375 cell line J Huazhong Univ Sci Technol Med Sci 29 771 775 1:CAS:528:DC%2BC3cXjtlKgtw%3D%3D 20037825
60. SC Bischoff 2008 Quercetin: potentials in the prevention and therapy of disease Curr Opin Clin Nutr Metab Care 11 733 740 1:CAS:528:DC%2BD1cXhtFOrtLnJ 18827577
61. DR Ferry A Smith J Malkhandi DW Fyfe PG deTakats D Anderson J Baker DJ Kerr 1996 Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition Clin Cancer Res 2 659 668 1:CAS:528:DyaK28Xis1Wltbg%3D 9816216
62. YH Kim YJ Lee 2007 TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation J Cell Biochem 100 998 1009 1:CAS:528:DC%2BD2sXhvFGlsr8%3D 17031854
63. YH Kim DH Lee JH Jeong ZS Guo YJ Lee 2008 Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway Biochem Pharmacol 75 1946 1958 1:CAS:528:DC%2BD1cXlsFOms7o%3D 18377872
64. M Russo P Nigro R Rosiello R D'Arienzo GL Russo 2007 Quercetin enhances CD95- and TRAIL-induced apoptosis in leukemia cell lines Leukemia 21 1130 1133 1:CAS:528:DC%2BD2sXksFeltL8%3D 17330100
65. W Chen X Wang J Zhuang L Zhang Y Lin 2007 Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells Carcinogenesis 28 2114 2121 1:CAS:528:DC%2BD2sXhtFeqsL7E 17548900
66. JY Kim EH Kim SS Park JH Lim TK Kwon KS Choi 2008 Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation J Cell Biochem 105 1386 1398 1:CAS:528:DC%2BD1cXhsFaks7fK 18980244
67. HL You HL Eng SF Hsu CM Chen TC Ye WT Liao MY Huang R Baer JT Cheng 2007 A PKC-Sp1 signaling pathway induces early differentiation of human keratinocytes through upregulation of TSG101 Cell Signal 19 1201 1211 1:CAS:528: DC%2BD2sXksV2mtLs%3D 17321722
68. FH Psahoulia KG Drosopoulos L Doubravska L Andera A Pintzas 2007 Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts Mol Cancer Ther 6 2591 2599 1:CAS:528:DC%2BD2sXhtVCgur%2FL 17876056
69. MD Siegelin DE Reuss A Habel A Rami A von Deimling 2009 Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells Neuro Oncol 11 122 131 1:CAS:528:DC%2BD1MXkvFentro%3D 18971417
70. H Hasegawa Y Yamada K Komiyama M Hayashi M Ishibashi T Yoshida T Sakai T Koyano TS Kam K Murata K Sugahara K Tsuruda N Akamatsu K Tsukasaki M Masuda N Takasu S Kamihira 2006 Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells Blood 107 679 688 1:CAS:528:DC%2BD28Xms1ersA%3D%3D 16195335
71. T Yoshida M Konishi M Horinaka T Yasuda AE Goda H Taniguchi K Yano M Wakada T Sakai 2008 Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis Biochem Biophys Res Commun 375 129 133 1:CAS:528:DC%2BD1cXhtVOit7zJ 18680719
72. LK Leung LS Po TY Lau YM Yuen 2004 Effect of dietary flavonols on oestrogen receptor transactivation and cell death induction Br J Nutr 91 831 839 1:CAS:528:DC%2BD2cXltlGmu7o%3D 15182386
73. MD Siegelin DE Reuss A Habel C Herold-Mende A von Deimling 2008 The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin Mol Cancer Ther 7 3566 3574 1:CAS:528:DC%2BD1cXhtlGgs77P 19001439
74. MD Siegelin T Gaiser A Habel Y Siegelin 2009 Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2 Cancer Lett 283 230 238 1:CAS:528: DC%2BD1MXptlanu78%3D 19398149
75. R Ravi A Bedi 2002 Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II Cancer Res 62 4180 4185 1:CAS:528:DC%2BD38XlvFelt7k%3D 12154014
76. M Horinaka T Yoshida T Shiraishi S Nakata M Wakada T Sakai 2006 The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand Mol Cancer Ther 5 945 951 1:CAS:528:DC%2BD28XjvFCktrc%3D 16648565
77. M Horinaka T Yoshida T Shiraishi S Nakata M Wakada R Nakanishi H Nishino T Sakai 2005 The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells Biochem Biophys Res Commun 333 833 838 1:CAS:528:DC%2BD2MXlvVent7g%3D 15963948
78. RX Shi CN Ong HM Shen 2005 Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells Cancer Res 65 7815 7823 1:CAS:528:DC%2BD2MXpslaiu70%3D 16140950
79. SC Fas S Baumann JY Zhu M Giaisi MK Treiber U Mahlknecht PH Krammer M Li-Weber 2006 Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis Blood 108 3700 3706 1:CAS:528:DC%2BD28Xht1Kgs7%2FP 16931628
80. DH Lee JG Rhee YJ Lee 2009 Reactive oxygen species up-regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin Br J Pharmacol 157 1189 1202 1:CAS:528:DC%2BD1MXhtVelt7bN 19438509
81. SA Rushworth O Micheau 2009 Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer Br J Pharmacol 157 1186 1188 1:CAS:528:DC%2BD1MXhtVelt7bM 19664138
82. G Kallifatidis V Rausch B Baumann A Apel BM Beckermann A Groth J Mattern Z Li A Kolb G Moldenhauer P Altevogt T Wirth J Werner P Schemmer MW Buchler AV Salnikov I Herr 2009 Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling Gut 58 949 963 1:CAS:528: DC%2BD1MXovFSktb0%3D 18829980
83. J Peng Q Qi Q You R Hu W Liu F Feng G Wang Q Guo 2009 Subchronic toxicity and plasma pharmacokinetic studies on wogonin, a natural flavonoid, in Beagle dogs J Ethnopharmacol 124 257 262 1:CAS:528:DC%2BD1MXnvVWktr4%3D 19397969
84. H Taniguchi T Yoshida M Horinaka T Yasuda AE Goda M Konishi M Wakada K Kataoka T Yoshikawa T Sakai 2008 Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells Cancer Res 68 8918 8927 1:CAS:528:DC%2BD1cXhtlSkur%2FF 18974136
85. MJ Messina CE Wood 2008 Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary Nutr J 7 17 18522734
86. SY Park DW Seol 2002 Regulation of Akt by EGF-R inhibitors, a possible mechanism of EGF-R inhibitor-enhanced TRAIL-induced apoptosis Biochem Biophys Res Commun 295 515 518 1:CAS:528:DC%2BD38XltFertLg%3D 12150980
87. F Nozawa A Itami M Saruc M Kim J Standop KS Picha KH Cowan PM Pour 2004 The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth Pancreas 29 45 52 1:CAS:528:DC%2BD2cXmtVSitLY%3D 15211111
88. MW Lee JH Bach HJ Lee DY Lee WS Joo YS Kim SC Park KY Kim WB Lee SS Kim 2005 The activation of ERK1/2 via a tyrosine kinase pathway attenuates trail-induced apoptosis in HeLa cells Cancer Investig 23 586 592 1:CAS:528:DC%2BD2MXht1eltLvN
89. CY Jin C Park GY Kim SJ Lee WJ Kim YH Choi 2009 Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells Chem Biol Interact 180 143 150 1:CAS:528:DC%2BD1MXmvF2itb0%3D 19497411
90. CY Jin C Park SK Moon GY Kim TK Kwon SJ Lee WJ Kim YH Choi 2009 Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage Anticancer Drugs 20 713 722 1:CAS:528: DC%2BD1MXovVOhtr0%3D 19617819
91. CY Jin C Park J Cheong BT Choi TH Lee JD Lee WH Lee GY Kim CH Ryu YH Choi 2007 Genistein sensitizes TRAIL-resistant human gastric adenocarcinoma AGS cells through activation of caspase-3 Cancer Lett 257 56 64 1:CAS:528: DC%2BD2sXhtFSnt7vK 17689858
92. MD Siegelin Y Siegelin A Habel T Gaiser 2009 Genistein enhances proteasomal degradation of the short isoform of FLIP in malignant glioma cells and thereby augments TRAIL-mediated apoptosis Neurosci Lett 453 92 97 1:CAS:528:DC%2BD1MXivVelu7k%3D 19356600
93. MD Siegelin T Gaiser A Habel Y Siegelin 2009 Daidzein overcomes TRAIL-resistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, Bcl-2 Neurosci Lett 454 223 228 1:CAS:528:DC%2BD1MXktFalt7o%3D 19429088
94. N Kim 2008 Butein sensitizes human leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis inducing ligand (TRAIL) Arch Pharm Res 31 1179 1186 1:CAS:528:DC%2BD1cXhtFegtbfJ 18806962
95. T Yoshida M Horinaka M Takara M Tsuchihashi N Mukai M Wakada T Sakai 2008 Combination of isoliquiritigenin and tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in colon cancer HT29 cells Environ Health Prev Med 13 281 287 1:CAS:528:DC%2BD1cXht1yntr3F 19568915
96. D Deeb YX Xu H Jiang X Gao N Janakiraman RA Chapman SC Gautam 2003 Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells Mol Cancer Ther 2 95 103 1:CAS:528:DC%2BD3sXhtlOit7s%3D 12533677
97. S Fulda KM Debatin 2004 Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol Cancer Res 64 337 346 1:CAS:528:DC%2BD2cXkslyrsA%3D%3D 14729643
98. S Fulda KM Debatin 2005 Resveratrol-mediated sensitisation to TRAIL-induced apoptosis depends on death receptor and mitochondrial signalling Eur J Cancer 41 786 798 1:CAS:528:DC%2BD2MXitF2isbw%3D 15763656
99. D Delmas C Rebe O Micheau A Athias P Gambert S Grazide G Laurent N Latruffe E Solary 2004 Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells Oncogene 23 8979 8986 1:CAS:528:DC%2BD2cXhtVWgtb%2FK 15480430
100. S Shankar Q Chen I Siddiqui K Sarva RK Srivastava 2007 Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4′, 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential J Mol Signal 2 7 17718901
101. S Shankar I Siddiqui RK Srivastava 2007 Molecular mechanisms of resveratrol (3, 4, 5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells Mol Cell Biochem 304 273 285 1:CAS:528:DC%2BD2sXhtVKrtrbN 17636462
102. C Gill SE Walsh C Morrissey JM Fitzpatrick RW Watson 2007 Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms Prostate 67 1641 1653 1:CAS:528:DC%2BD2sXhtlyrtL7L 17823925
103. DA Sallman X Chen B Zhong DL Gilvary J Zhou S Wei JY Djeu 2007 Clusterin mediates TRAIL resistance in prostate tumor cells Mol Cancer Ther 6 2938 2947 1:CAS:528:DC%2BD2sXhtlWkt7bI 18025278
104. VN Ivanov MA Partridge GE Johnson SX Huang H Zhou TK Hei 2008 Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression Exp Cell Res 314 1163 1176 1:CAS:528:DC%2BD1cXisVWjtbg%3D 18222423
105. T Yoshida T Shiraishi M Horinaka S Nakata T Yasuda AE Goda M Wakada Y Mizutani T Miki A Nishikawa T Sakai 2007 Lipoxygenase inhibitors induce death receptor 5/TRAIL-R2 expression and sensitize malignant tumor cells to TRAIL-induced apoptosis Cancer Sci 98 1417 1423 1:CAS:528:DC%2BD2sXhtVaksrvO 17645780
106. SM Raja S Chen P Yue TM Acker B Lefkove JL Arbiser FR Khuri SY Sun 2008 The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis Mol Cancer Ther 7 2212 2223 1:CAS:528:DC%2BD1cXoslCnsrk%3D 18645030
107. YG Son EH Kim JY Kim SU Kim TK Kwon AR Yoon CO Yun KS Choi 2007 Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin Cancer Res 67 8274 8284 1:CAS:528:DC%2BD2sXpvFKju74%3D 17804742
108. S Reuter S Eifes M Dicato BB Aggarwal M Diederich 2008 Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells Biochem Pharmacol 76 1340 1351 1:CAS:528: DC%2BD1cXhtl2qtLbM 18755156
109. AS Strimpakos RA Sharma 2008 Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials Antioxid Redox Signal 10 511 545 1:CAS:528:DC%2BD1cXmt1yksQ%3D%3D 18370854
110. DD Deeb H Jiang X Gao G Divine SA Dulchavsky SC Gautam 2005 Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis J Exp Ther Oncol 5 81 91 1:CAS:528:DC%2BD2MXhtlWntr%2FE 16471035
111. D Deeb H Jiang X Gao MS Hafner H Wong G Divine RA Chapman SA Dulchavsky SC Gautam 2004 Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation Mol Cancer Ther 3 803 812 1:CAS:528:DC%2BD2cXls1amsr8%3D 15252141
112. D Deeb H Jiang X Gao S Al-Holou AL Danyluk SA Dulchavsky SC Gautam 2007 Curcumin [1, 7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3, 5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway J Pharmacol Exp Ther 321 616 625 1:CAS:528:DC%2BD2sXltFehur4%3D 17289836
113. T Andrzejewski D Deeb X Gao A Danyluk AS Arbab SA Dulchavsky SC Gautam 2008 Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer Oncol Res 17 257 267 1:CAS:528: DC%2BD1MXnslWhu74%3D 19192720
114. S Shankar Q Chen K Sarva I Siddiqui RK Srivastava 2007 Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis J Mol Signal 2 10 17916240
115. S Shankar S Ganapathy Q Chen RK Srivastava 2008 Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis Mol Cancer 7 16 18226269
116. EM Jung JW Park KS Choi HI Lee KS Lee TK Kwon 2006 Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation Carcinogenesis 27 2008 2017 1:CAS:528:DC%2BD28XhtVOmu77J 16613838
117. EM Jung JH Lim TJ Lee JW Park KS Choi TK Kwon 2005 Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5) Carcinogenesis 26 1905 1913 1:CAS:528:DC%2BD2MXhtFCjt7vN 15987718
118. AR Hussain M Ahmed NA Al-Jomah AS Khan P Manogaran M Sultana J Abubaker LC Platanias KS Al-Kuraya S Uddin 2008 Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines Mol Cancer Ther 7 3318 3329 1:CAS:528:DC%2BD1cXht1ensb%2FL 18852135
119. X Gao D Deeb H Jiang YB Liu SA Dulchavsky SC Gautam 2005 Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria J Exp Ther Oncol 5 39 48 16416600
120. AM Kamat G Sethi BB Aggarwal 2007 Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells Mol Cancer Ther 6 1022 1030 1:CAS:528:DC%2BD2sXivV2nt78%3D 17363495
121. H Wahl L Tan K Griffith M Choi JR Liu 2007 Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells Gynecol Oncol 105 104 112 1:CAS:528:DC%2BD2sXjsVems7g%3D 17174384 (Pubitemid 46442871)
122. CK Kong WS Lam LC Chiu VE Ooi SS Sun YS Wong 2009 A rice bran polyphenol, cycloartenyl ferulate, elicits apoptosis in human colorectal adenocarcinoma SW480 and sensitizes metastatic SW620 cells to TRAIL-induced apoptosis Biochem Pharmacol 77 1487 1496 1:CAS:528:DC%2BD1MXktF2rsr8%3D 19426686
123. M Drees WA Dengler T Roth H Labonte J Mayo L Malspeis M Grever EA Sausville HH Fiebig 1997 Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells Clin Cancer Res 3 273 279 1:CAS:528:DyaK2sXhsVOmtro%3D 9815683
124. GI Shapiro 2004 Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol Clin Cancer Res 10 4270s 4275s 1:CAS:528:DC%2BD2cXltFWls7o%3D 15217973
125. M Taniai A Grambihler H Higuchi N Werneburg SF Bronk DJ Farrugia SH Kaufmann GJ Gores 2004 Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells Cancer Res 64 3517 3524 1:CAS:528:DC%2BD2cXktVWhsb4%3D 15150106
126. RR Rosato Y Dai JA Almenara SC Maggio S Grant 2004 Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation Leukemia 18 1780 1788 1:CAS:528:DC%2BD2cXovVGitb8%3D 15385934
127. K Miyashita K Shiraki H Fuke T Inoue Y Yamanaka Y Yamaguchi N Yamamoto K Ito K Sugimoto T Nakano 2006 The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis Int J Mol Med 18 249 256 1:CAS:528:DC%2BD28XotFKhtb4%3D 16820931
128. C Palacios R Yerbes A Lopez-Rivas 2006 Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cells Cancer Res 66 8858 8869 1:CAS:528:DC%2BD28XovF2ht7s%3D 16951203
129. TE Fandy DD Ross SD Gore RK Srivastava 2007 Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPL Cancer Chemother Pharmacol 60 313 319 1:CAS:528:DC%2BD2sXmsVOjsr8%3D 17187253
130. DM Kim SY Koo K Jeon MH Kim J Lee CY Hong S Jeong 2003 Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines Cancer Res 63 621 626 1:CAS:528:DC%2BD3sXosVyisg%3D%3D 12566305
131. DJ Newman GM Cragg 2007 Natural products as sources of new drugs over the last 25 years J Nat Prod 70 461 477 1:CAS:528:DC%2BD2sXhvFKrsro%3D 17309302
132. AK Garg TA Buchholz BB Aggarwal 2005 Chemosensitization and radiosensitization of tumors by plant polyphenols Antioxid Redox Signal 7 1630 1647 1:CAS:528:DC%2BD2MXhtlWht73M 16356126
133. M Ishibashi T Ohtsuki 2008 Studies on search for bioactive natural products targeting TRAIL signaling leading to tumor cell apoptosis Med Res Rev 28 688 714 1:CAS:528:DC%2BD1cXhtV2qsLvN 18273883
134. E Szliszka ZP Czuba M Domino B Mazur G Zydowicz W Krol 2009 Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells Molecules 14 738 754 1:CAS:528:DC%2BD1MXisVWhtbc%3D 19223822
135. B Sung B Park VR Yadav BB Aggarwal 2010 Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors J Biol Chem 285 11498 11507 1:CAS:528:DC%2BC3cXktFGlt7o%3D 20154087
136. H Zhu WJ Ding R Wu QJ Weng JS Lou RJ Jin W Lu B Yang QJ He 2010 Synergistic anti-cancer activity by the combination of TRAIL/APO-2L and celastrol Cancer Investig 28 23 32 1:CAS:528:DC%2BD1MXhsFCiu7rE
137. I Murtaza M Saleem VM Adhami BB Hafeez H Mukhtar 2009 Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells Cancer Res 69 1156 1165 1:CAS:528:DC%2BD1MXhtFOlu78%3D 19176377
138. A Scalbert G Williamson 2000 Dietary intake and bioavailability of polyphenols J Nutr 130 2073S 2085S 1:CAS:528:DC%2BD3cXltl2gsLw%3D 10917926
139. PA Kroon MN Clifford A Crozier AJ Day JL Donovan C Manach G Williamson 2004 How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr 80 15 21 1:CAS:528:DC%2BD2cXltlKlsbc%3D 15213022
140. S Das KY Ng 2010 Resveratrol-loaded calcium-pectinate beads: effects of formulation parameters on drug release and bead characteristics J Pharm Sci 99 840 860 1:CAS:528:DC%2BD1MXhsF2jsLvF 19653272
141. NK Narayanan D Nargi C Randolph BA Narayanan 2009 Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice Int J Cancer 125 1 8 1:CAS:528:DC%2BD1MXmslCguro%3D 19326431
142. JY Fang WR Lee SC Shen YL Huang 2006 Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas J Dermatol Sci 42 101 109 1:CAS:528:DC%2BD28XjvVagur4%3D 16423506
143. ZP Yuan LJ Chen LY Fan MH Tang GL Yang HS Yang XB Du GQ Wang WX Yao QM Zhao B Ye R Wang P Diao W Zhang HB Wu X Zhao YQ Wei 2006 Liposomal quercetin efficiently suppresses growth of solid tumors in murine models Clin Cancer Res 12 3193 3199 1:CAS:528:DC%2BD28Xks1Chsrw%3D 16707620
144. CF Hung YK Lin ZR Huang JY Fang 2008 Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin Biol Pharm Bull 31 955 962 1:CAS:528:DC%2BD1cXotF2mt7c%3D 18451526